PURPOSE: Endoscopic examination has proven effective in both detecting and preventing colorectal cancer; however, only about a quarter of eligible patients undergo screening. Even if the compliance rate increased, limited endoscopic capacity and cost would be prohibitive. There is a need for an accurate method to target colonoscopy to those most at risk of harboring colonic neoplasia. Exploiting field carcinogenesis seems to be a promising avenue. Our group recently reported that an early increase in blood supply (EIBS) is a reliable marker of field carcinogenesis in experimental models. We now investigate whether in situ detection of EIBS in the rectum can predict neoplasia elsewhere in the colon. EXPERIMENTAL DESIGN: We developed a novel polarization-gated spectroscopy fiber-optic probe that allows depth-selective interrogation of microvascular blood content. Using the probe, we examined the blood content in vivo from the rectal mucosa of 216 patients undergoing screening colonoscopy. RESULTS: Microvascular blood content was increased by approximately 50% in the endoscopically normal rectal mucosa of patients harboring advanced adenomas when compared with neoplasia-free patients irrespective of lesion location. Demographic factors and nonneoplastic lesions did not confound this observation. Logistic regression using mucosal oxyhemoglobin concentration and patient age resulted in a sensitivity of 83%, a specificity of 82%, and an area under the receiver operating characteristic curve of 0.88 for the detection of advanced adenomas. CONCLUSIONS: Increased microvascular blood supply in the normal rectal mucosa is associated with the presence of clinically significant neoplasia elsewhere in the colon, supporting the development of rectal EIBS as a colon cancer risk-stratification tool.
PURPOSE: Endoscopic examination has proven effective in both detecting and preventing colorectal cancer; however, only about a quarter of eligible patients undergo screening. Even if the compliance rate increased, limited endoscopic capacity and cost would be prohibitive. There is a need for an accurate method to target colonoscopy to those most at risk of harboring colonic neoplasia. Exploiting field carcinogenesis seems to be a promising avenue. Our group recently reported that an early increase in blood supply (EIBS) is a reliable marker of field carcinogenesis in experimental models. We now investigate whether in situ detection of EIBS in the rectum can predict neoplasia elsewhere in the colon. EXPERIMENTAL DESIGN: We developed a novel polarization-gated spectroscopy fiber-optic probe that allows depth-selective interrogation of microvascular blood content. Using the probe, we examined the blood content in vivo from the rectal mucosa of 216 patients undergoing screening colonoscopy. RESULTS: Microvascular blood content was increased by approximately 50% in the endoscopically normal rectal mucosa of patients harboring advanced adenomas when compared with neoplasia-freepatients irrespective of lesion location. Demographic factors and nonneoplastic lesions did not confound this observation. Logistic regression using mucosal oxyhemoglobin concentration and patient age resulted in a sensitivity of 83%, a specificity of 82%, and an area under the receiver operating characteristic curve of 0.88 for the detection of advanced adenomas. CONCLUSIONS: Increased microvascular blood supply in the normal rectal mucosa is associated with the presence of clinically significant neoplasia elsewhere in the colon, supporting the development of rectal EIBS as a colon cancer risk-stratification tool.
Authors: James D Lewis; Kimmie Ng; Kenneth E Hung; Warren B Bilker; Jesse A Berlin; Colleen Brensinger; Anil K Rustgi Journal: Arch Intern Med Date: 2003-02-24
Authors: Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'Brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: N Gopalswamy; V N Shenoy; U Choudhry; R J Markert; N Peace; M S Bhutani; C J Barde Journal: Gastrointest Endosc Date: 1997-12 Impact factor: 9.427
Authors: Hemant K Roy; Yang Liu; Ramesh K Wali; Young L Kim; Alexei K Kromine; Michael J Goldberg; Vadim Backman Journal: Gastroenterology Date: 2004-04 Impact factor: 22.682
Authors: C Daniel Johnson; Mei-Hsiu Chen; Alicia Y Toledano; Jay P Heiken; Abraham Dachman; Mark D Kuo; Christine O Menias; Betina Siewert; Jugesh I Cheema; Richard G Obregon; Jeff L Fidler; Peter Zimmerman; Karen M Horton; Kevin Coakley; Revathy B Iyer; Amy K Hara; Robert A Halvorsen; Giovanna Casola; Judy Yee; Benjamin A Herman; Lawrence J Burgart; Paul J Limburg Journal: N Engl J Med Date: 2008-09-18 Impact factor: 91.245
Authors: Ashish K Tiwari; Susan E Crawford; Andrew Radosevich; Ramesh K Wali; Yolanda Stypula; Dhananjay P Kunte; Nikhil Mutyal; Sarah Ruderman; Andrew Gomes; Mona L Cornwell; Mart De La Cruz; Jeffrey Brasky; Tina P Gibson; Vadim Backman; Hemant K Roy Journal: Cancer Lett Date: 2011-04-14 Impact factor: 8.679
Authors: Vadim Backman; Hemant K Roy; Andrew J Radosevich; Nikhil N Mutyal; Adam Eshein; The-Quyen Nguyen; Bradley Gould; Jeremy D Rogers; Michael J Goldberg; Laura K Bianchi; Eugene F Yen; Vani Konda; Douglas K Rex; Jacques Van Dam Journal: Clin Cancer Res Date: 2015-05-19 Impact factor: 12.531
Authors: Eladio Rodriguez-Diaz; Christopher Atkinson; Lisa I Jepeal; Adam Berg; Christopher S Huang; Sandra R Cerda; Michael J OʼBrien; Irving J Bigio; Francis A Farraye; Satish K Singh Journal: Inflamm Bowel Dis Date: 2014-06 Impact factor: 5.325
Authors: Hemant K Roy; Andrew J Gomes; Sarah Ruderman; Laura K Bianchi; Michael J Goldberg; Valentina Stoyneva; Jeremy D Rogers; Vladimir Turzhitsky; Young Kim; Eugene Yen; Mohammed Jameel; Andrej Bogojevic; Vadim Backman Journal: Cancer Prev Res (Phila) Date: 2010-06-22
Authors: Andrew J Gomes; Sarah Ruderman; Mart DelaCruz; Ramesh K Wali; Hemant K Roy; Vadim Backman Journal: J Biomed Opt Date: 2012-04 Impact factor: 3.170